Heart News and Research

RSS

Pregnant, postnatal women follow mothers’ and grandmothers' advice rather than medical guidelines

Researchers from Royal Holloway, University of London have found that pregnant and postnatal women, while wanting to do the best for their baby, do not follow medical advice without question and are more likely to adopt practices their mothers and grandmothers carried out during their pregnancies.

15 May 2010

Research sheds light on early embryogenesis, genetic disease

Chromosome 22q11 deletion syndrome (also known as DiGeorge syndrome) is the most common human chromosome deletion syndrome, having an estimated incidence of at least one in 4,000 live births.

15 May 2010

Merck, Cardiome Pharma show superiority of BRINAVESS to amiodarone injection

In a new Phase III study, BRINAVESSTM (vernakalant) intravenous, an investigational compound being developed in the European Union by Merck (known as MSD outside the USA and Canada) and Cardiome Pharma Corp. to treat atrial fibrillation, showed that BRINAVESS was superior to amiodarone injection, in converting patients' heart rate from atrial fibrillation (AF) to sinus rhythm (SR) within 90 minutes of the start of administration.

15 May 2010

New GE SPHHS building to serve as convening place for public health leaders

The George Washington University announced today plans to begin construction of a new building for its School of Public Health and Health Services on Pennsylvania Avenue, to be completed in the summer of 2014.

15 May 2010

UC researchers explore dynamics of bacterial evolution

Researchers found that as dominant members of the population surrendered to host immune defenses, they were replaced by a hyperaggressive, mutant minority population that thrived and took over the abandoned community to become the new majority.

15 May 2010

Zargis Cardioscan device, 3M Littmann Electronic Stethoscope Model 3200 recognized with Gold Award

Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp., today announced that its Zargis Cardioscan device and the compatible 3M Littmann Electronic Stethoscope Model 3200 were the joint recipients of a Gold Award on April 29th at The Edison Best New Products Award gala, presented by Discovery Channel in New York City.

15 May 2010

Opinions: Africans fight malaria; Access to AIDS treatment; Noncommunicable disease summit; Maternal, child health efforts

In an East African opinion piece, U.N. Special Envoy for Malaria Ray Chambers; Mark Green, the director of the Malaria No More Policy Center; and John Bridgeland, vice chairman of Malaria No More, highlight Africans' involvement in addressing malaria on the continent.

15 May 2010

Study examines safety of non-invasive cardiac shock wave procedure for angina pectoris

UC San Diego Health System is enrolling a small group of patients in a two-year study to examine the safety of a non-invasive cardiac shock wave procedure for patients with chest pain caused by insufficient blood flow to the heart.

15 May 2010

Fat tissue different in men and women

The age-old question of why men store fat in their bellies and women store it in their hips may have finally been answered: Genetically speaking, the fat tissue is almost completely different.

15 May 2010

STOP AF trial: Arctic Front Cardiac CryoAblation Catheter System reduces AF symptoms by 80%

Medtronic, Inc. today released new STOP AF clinical trial data showing the number of paroxysmal atrial fibrillation patients reporting AF symptoms declined by 80 percent after treatment with the Arctic Front Cardiac CryoAblation Catheter System.

15 May 2010

Heart defibrillators complicate end-of-life care

Heart defibrillators, "small implants that save lives by sending an electrical jolt to interrupt a potentially fatal heart rhythm and restore normal beating," can pose a "challenge near life's end, for both patients and their families," The New York Times reports.

14 May 2010

Convergent procedure promising for longstanding persistent atrial fibrillation

nContact Surgical, Inc. announced today the presentation of data collected from 43 patients as a result of a closed chest convergent atrial fibrillation (AF) procedure at the Heart Rhythm Society 2010 Conference in Denver, Colorado.

14 May 2010

Nile Therapeutics reports net loss of $1.9M for first-quarter 2010

Nile Therapeutics, Inc., a company focused on the development of novel therapeutics for heart failure patients, today announced its first quarter financial results for 2010.

14 May 2010

Medtronic releases Virtual ICD study data

Medtronic, Inc. released the Virtual ICD study data today that predicted 98 percent of studied implantable defibrillator patients would be free of inappropriate shocks one year after implant and 92 percent at five years post-implant.

14 May 2010

Ambulance fees will deter emergency calls for help and risks lives: Study

Multiple data sources, including scientific survey data, medical studies and analyses of data in regions that have imposed ambulance fees, indicate that ambulance fees will discourage calls to emergency services for help, risking the health and safety of those experiencing medical emergencies.

14 May 2010

Catheter ablation treatment reduces risks associated with atrial fibrillation

New findings by researchers from the Heart Institute at Intermountain Medical Center in Murray, Utah, reveals treatment of the most common heart rhythm disorder that affects more than two million Americans significantly reduces the risk of stroke, mortality, Alzheimer's disease and other forms of dementia.

14 May 2010

FREEDOM trial results to be presented at Heart Rhythm 2010

St. Jude Medical, Inc., a global medical device company, today announced results of the FREEDOM trial during the late breaking clinical trial presentations at Heart Rhythm 2010, the Heart Rhythm Society's 31st Annual Scientific Sessions. The trial demonstrated that the QuickOpt optimization feature available in St. Jude Medical cardiac resynchronization therapy devices produces an equivalent response rate in CRT patients as optimization using echocardiography.

14 May 2010

St. Jude Medical announces FDA clearance and CE Mark approval for EnSite Derexi module

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) clearance, CE Mark approval and the launch of the EnSite Derexi™ module, which provides improved electrophysiology (EP) lab efficiency and workflow by enabling communication between the EnSite™ Velocity™ Cardiac Mapping System and the EP-Workmate™ Recording System.

14 May 2010

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

Geron Corporation today reported positive preclinical study data showing that GRNCM1, Geron's cardiomyocyte product derived from human embryonic stem cells, does not cause cardiac arrhythmias after transplantation into a model of chronic heart damage designed to test this potential safety concern.

14 May 2010

Interleukin Genetics reports 166% increase in overall genetic test revenue for first-quarter 2010

Interleukin Genetics, Inc. announced today financial and operational results for the first quarter ended March 31, 2010.

14 May 2010

Heart News and Research

Pregnant, postnatal women follow mothers’ and grandmothers' advice rather than medical guidelines

Research sheds light on early embryogenesis, genetic disease

Merck, Cardiome Pharma show superiority of BRINAVESS to amiodarone injection

New GE SPHHS building to serve as convening place for public health leaders

UC researchers explore dynamics of bacterial evolution

Zargis Cardioscan device, 3M Littmann Electronic Stethoscope Model 3200 recognized with Gold Award

Opinions: Africans fight malaria; Access to AIDS treatment; Noncommunicable disease summit; Maternal, child health efforts

Study examines safety of non-invasive cardiac shock wave procedure for angina pectoris

Fat tissue different in men and women

STOP AF trial: Arctic Front Cardiac CryoAblation Catheter System reduces AF symptoms by 80%

Heart defibrillators complicate end-of-life care

Convergent procedure promising for longstanding persistent atrial fibrillation

Nile Therapeutics reports net loss of $1.9M for first-quarter 2010

Medtronic releases Virtual ICD study data

Ambulance fees will deter emergency calls for help and risks lives: Study

Catheter ablation treatment reduces risks associated with atrial fibrillation

FREEDOM trial results to be presented at Heart Rhythm 2010

St. Jude Medical announces FDA clearance and CE Mark approval for EnSite Derexi module

GRNCM1 do not cause cardiac arrhythmias after transplantation: Preclinical study

Interleukin Genetics reports 166% increase in overall genetic test revenue for first-quarter 2010

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News